This association bears great therapeutical potential, as allosteric activators of glucocerebrosidase restore lysosomal function [61] and have recently been proven safe in humans [62], underscoring the possibility of extending their application to management of AD in APOE4 carriers. The gene discussed is GBA1; the disease is Alzheimer disease.